Eleni Bekiari

4.9k total citations · 3 hit papers
72 papers, 2.8k citations indexed

About

Eleni Bekiari is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Eleni Bekiari has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in Eleni Bekiari's work include Diabetes Treatment and Management (31 papers), Diabetes Management and Research (23 papers) and Metabolism, Diabetes, and Cancer (16 papers). Eleni Bekiari is often cited by papers focused on Diabetes Treatment and Management (31 papers), Diabetes Management and Research (23 papers) and Metabolism, Diabetes, and Cancer (16 papers). Eleni Bekiari collaborates with scholars based in Greece, United Kingdom and United States. Eleni Bekiari's co-authors include Απόστολος Τσάπας, Thomas Karagiannis, Aris Liakos, David R. Matthews, Eleni Athanasiadou, Ioannis Avgerinos, Maria Mainou, Maria Sarigianni, Konstantinos Malandris and Apostolos Manolopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Diabetes Care.

In The Last Decade

Eleni Bekiari

69 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

2013 690 citations Thomas Karagiannis, Eleni Athanasiadou et al. profile →
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

2018 308 citations Eleni Bekiari, Konstantinos Kitsios et al. BMJ profile →
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

2022 176 citations Thomas Karagiannis, Ioannis Avgerinos et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eleni Bekiari Greece	23	2.2k	969	914	482	313	72	2.8k
Serge Jabbour United States	28	2.3k 1.0×	896 0.9×	1.1k 1.2×	428 0.9×	261 0.8×	78	3.0k
Murray Stewart United Kingdom	31	2.2k 1.0×	975 1.0×	1.2k 1.3×	442 0.9×	358 1.1×	68	3.1k
Curtis Triplitt United States	30	1.8k 0.8×	834 0.9×	1.1k 1.2×	246 0.5×	527 1.7×	89	2.7k
M. Nauck Germany	3	2.8k 1.3×	828 0.9×	1.1k 1.2×	284 0.6×	309 1.0×	5	3.3k
Adie Viljoen United Kingdom	25	1.9k 0.9×	873 0.9×	1.1k 1.2×	724 1.5×	507 1.6×	98	3.3k
Marcel H.A. Muskiet Netherlands	28	2.5k 1.1×	1.1k 1.2×	870 1.0×	442 0.9×	412 1.3×	66	3.5k
Carol Wysham United States	23	2.6k 1.2×	922 1.0×	1.0k 1.1×	635 1.3×	344 1.1×	77	3.1k
Vincent Woo Canada	33	4.0k 1.8×	1.6k 1.7×	1.6k 1.8×	614 1.3×	337 1.1×	93	4.5k
Marija Zdravković Serbia	20	2.0k 0.9×	902 0.9×	1.2k 1.3×	524 1.1×	283 0.9×	146	3.2k
Ilaria Dicembrini Italy	35	2.5k 1.1×	857 0.9×	1.2k 1.3×	370 0.8×	333 1.1×	87	3.3k

Countries citing papers authored by Eleni Bekiari

Since Specialization

Citations

This map shows the geographic impact of Eleni Bekiari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Bekiari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Bekiari more than expected).

Fields of papers citing papers by Eleni Bekiari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni Bekiari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Bekiari. The network helps show where Eleni Bekiari may publish in the future.

Co-authorship network of co-authors of Eleni Bekiari

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni Bekiari. A scholar is included among the top collaborators of Eleni Bekiari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni Bekiari. Eleni Bekiari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anyfanti, Panagiota, et al.. (2024). Cardiovascular Risk in Rheumatoid Arthritis: Considerations on Assessment and Management. Mediterranean Journal of Rheumatology. 35(3). 402–402. 4 indexed citations

Anyfanti, Panagiota, et al.. (2024). Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis. Diagnostics. 14(8). 834–834. 5 indexed citations

Malandris, Konstantinos, Emmanouil Korakas, Georgios Kalopitas, et al.. (2024). Accuracy of Controlled Attenuation Parameter for Liver Steatosis in High-Risk Patients for MASLD Using MRI-Proton Density Fat Fraction as Reference Standard. Digestive Diseases and Sciences. 70(2). 814–824.

Mantsiou, Chrysanthi, Aris Liakos, Maria Mainou, et al.. (2023). A Simple Guide to Systematic Reviews and Meta-Analyses. The International Journal of Lower Extremity Wounds. 24(4). 894–899. 4 indexed citations

Malandris, Konstantinos, Ioannis Avgerinos, Thomas Karagiannis, et al.. (2023). Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis. HORMONES. 22(4). 655–664. 5 indexed citations

Avgerinos, Ioannis, Thomas Karagiannis, David R. Matthews, Απόστολος Τσάπας, & Eleni Bekiari. (2023). Effects of sodium‐glucose co‐transporter‐2 inhibitors by background cardiovascular medications: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 25(10). 3020–3029. 5 indexed citations

Karagiannis, Thomas, Eleni Bekiari, & Απόστολος Τσάπας. (2023). Socioeconomic aspects of incretin-based therapy. Diabetologia. 66(10). 1859–1868. 34 indexed citations

Anyfanti, Panagiota, Eleni Bekiari, Alexandros Garyfallos, et al.. (2023). Peripheral nailfold capillary microscopic abnormalities in rheumatoid arthritis are associated with arterial stiffness: Results from a cross-sectional study. Microvascular Research. 150. 104576–104576. 2 indexed citations

Anyfanti, Panagiota, et al.. (2022). JAK Inhibition in Patients with Rheumatoid Arthritis: Haemodynamic Effects and Impact on Micro- and Macrovascular Function. Study Design and Rationale. Mediterranean Journal of Rheumatology. 33(4). 471–471. 5 indexed citations

10.

Avgerinos, Ioannis, Thomas Karagiannis, Aris Liakos, et al.. (2021). Ultra‐rapid‐acting insulins for adults with diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 23(10). 2395–2401. 22 indexed citations

11.

Avgerinos, Ioannis, Thomas Karagiannis, Aris Liakos, et al.. (2021). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 24(1). 106–114. 27 indexed citations

12.

Karagiannis, Thomas, Απόστολος Τσάπας, Eleni Athanasiadou, et al.. (2021). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 174. 108737–108737. 88 indexed citations

13.

Anyfanti, Panagiota, et al.. (2021). Monitoring and Managing Cardiovascular Risk in Immune Mediated Inflammatory Diseases. Journal of Inflammation Research. Volume 14. 6893–6906. 14 indexed citations

14.

Avgerinos, Ioannis, Apostolos Manolopoulos, Konstantinos Kitsios, et al.. (2020). Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis. Diabetes Obesity and Metabolism. 23(3). 822–831. 29 indexed citations

15.

Avgerinos, Ioannis, Aris Liakos, Thomas Karagiannis, et al.. (2019). Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 22(3). 335–345. 56 indexed citations

16.

Avgerinos, Ioannis, Aris Liakos, Απόστολος Τσάπας, & Eleni Bekiari. (2019). <p>Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 2549–2557. 4 indexed citations

17.

Bekiari, Eleni, Konstantinos Kitsios, Hood Thabit, et al.. (2018). Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 361. k1310–k1310. 308 indexed citations breakdown →

18.

Bekiari, Eleni, Aris Liakos, Maria Sarigianni, et al.. (2016). Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis. Endocrine. 54(3). 620–633. 2 indexed citations

19.

Vlachaki, Efthymia, et al.. (2012). Erythrocytosis Secondary to Testosterone Therapy in a Male with Cryptorchidism: A Case Report. SHILAP Revista de lepidopterología. 6(4). 290–291. 2 indexed citations

20.

Vlachaki, Efthymia, et al.. (2012). Safety And Efficacy Of 4 Years Of Deferasirox Treatment For Sickle Cell Disease Patients. Hemoglobin. 37(1). 94–100. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact